NextCure Inc. (NXTC)
NASDAQ: NXTC
· Real-Time Price · USD
5.16
0.01 (0.24%)
At close: Aug 15, 2025, 2:56 PM
0.24% (1D)
| Bid | 3.64 |
| Market Cap | 13.8M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -49.52M |
| EPS (ttm) | -25.97 |
| PE Ratio (ttm) | -0.2 |
| Forward PE | -0.3 |
| Analyst | Buy |
| Ask | 6.57 |
| Volume | 7,775 |
| Avg. Volume (20D) | 119,089 |
| Open | 5.09 |
| Previous Close | 5.15 |
| Day's Range | 5.01 - 5.22 |
| 52-Week Range | 2.69 - 19.80 |
| Beta | 1.26 |
About NXTC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NXTC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NXTC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+1.15%
NextCure shares are trading higher after the compa...
Unlock content with
Pro Subscription
8 months ago
+1.55%
NextCure shares are trading higher after the company highlighted data demonstrating that NC605 resulted in enhanced generation of quality bone and better mechanical properties.
